Biktarvy, formally known as bictegravir sulfate, represents a potent single-tablet regimen for treating HIV infection. This drug unites three key antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It functions by blocking the the viral ability to replicate within the body, considerably lowering the viral burden. For many